Korean J Pediatr Hematol Oncol.  2003 Apr;10(1):105-109.

Acute Lymphoblastic Leukemia in a Jehovah's Witness Girl

Affiliations
  • 1Department of Pediatrics, Inje University College of Medicine, Pusan Paik Hospital, Pusan, Korea. pedslee@ijnc.inje.ac.kr

Abstract

Recent advances in the treatment of leukemia are closely related to the development of intensive chemotherapy, which needs multiple blood transfusions during bone marrow suppression. Patients of the Jehovah's Witness refuse blood transfusions and therefore hematologists are faced with major dilemma in the treatment of these patients with leukemia. We report an 11-year-old girl of Jehovah's Witness with acute lymphoblastic leukemia, who refused blood transfusions during chemotherapy. She was treated by intensive chemotherapy and her remission and induction was successful with the support of G-CSF and erythropoietin. She has been in remission state for over 6 years since the completion of chemotherapy. We also made a brief review of related literatures.

Keyword

Acute Lymphoblastic Leukemia; Jehovah's Witness; Erythropoietin; G-CSF

MeSH Terms

Blood Transfusion
Bone Marrow
Child
Drug Therapy
Erythropoietin
Female*
Granulocyte Colony-Stimulating Factor
Humans
Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Erythropoietin
Granulocyte Colony-Stimulating Factor
Full Text Links
  • KJPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr